Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Hanwha Aerospace signed a new product supply contract exceeding 2.5% of its recent annual revenue, but withheld specific terms including contract amount and counterparty until December 31, 2024, due to business confidentiality.
📊 [Key Disclosure Details & Summary of Figures]
- Company Name: Hanwha Aerospace Co., Ltd.
- Ticker Symbol: 012450
- Disclosure Type: Single Sales/Supply Contract
- Disclosure Date: 2024-09-05
- Contract Classification: Product Supply
- Contract/Order Date & Commencement Date: 2024-09-04
- Reference Annual Revenue: KRW 9,359,005,981,309 (Based on 2023 consolidated revenue)
- Withholding Information:
- Reason for Withholding: Business Confidentiality
- Withholding Expiration Date: 2024-12-31
- Withheld Details: Contract title, contract amount, ratio to revenue, counterparty, sales/supply region, completion date, key terms
- Other Remarks: The contract amount meets the mandatory disclosure threshold of 2.5% or more of recent revenue (at least approx. KRW 234.0B+); details will be re-disclosed upon expiration or resolution of confidentiality conditions.
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Monitoring Re-disclosure of Contract Details Upon Confidentiality Expiration
This disclosure confirms a major supply contract where key commercial terms have been temporarily withheld due to business confidentiality. Reviewing the subsequent corrective disclosure upon expiration of the confidentiality period (scheduled for December 31, 2024) is essential for evaluating the total contract value and its revenue impact on the company’s order backlog. Final terms can be verified in future corrective disclosures and the “Business Overview – Order Status” section of upcoming Periodic Reports.
📢 Disclaimer and Source Notice
Source: This content was newly structured and generated based on official submission data from the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).
Investment Risk Notice: This content is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial liabilities rest entirely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
